Phase 2 Human Immunodeficiency Virus (HIV) Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800

Recruiting

Phase 2

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Cardiovascular Risk FactorHuman Immunodeficiency Virus (HIV)

Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT07030920